Sylvie Fournel‐Gigleux

Author

Centre National de la Recherche Scientifique ORCID

Also Known As

Fournel-Gigleux, Sylvie, S Fournel-Gigleux, S. Fournel-Gigleux, S. Fournelgigleux, Sylvie FOURNEL‐GIGLEUX, Sylvie Fournel-Gigleux, Sylvie Fournel‐Gigleux, sylvie Fournel-Gigleux

128

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

Centre National de la Recherche Scientifique Université de Lorraine Centre de Médecine Préventive University of Dundee Ninewells Hospital

About

Sylvie Fournel‐Gigleux is an author at Centre National de la Recherche Scientifique specializing in biochemistry, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	22	31	1.4K
2	Medicine	21	31	1.5K
3	Natural Sciences	21	27	1.2K
4	Health Sciences	3	3	139
5	Engineering	1	1	93

Sylvie Fournel‐Gigleux

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
The 2017 international classification of the Ehlers–Danlos syndromes Fransiska Malfait, Clair A. Francomano, Peter H. Byers, American Journal of Medical Genetics Part C Seminars in Medical Genetics	2017	1.8K
Interleukin-1? down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: Influence of glucosamine on interleukin-1?-mediated effects in rat chondrocytes Jean-Noël Gouze, Karim Bordji, Sandrine Gulberti, Arthritis & Rheumatism	2001	183
Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. David Harding, Sylvie Fournel‐Gigleux, Michael R. Jackson, Proceedings of the National Academy of Sciences Molecular RegulationGlycobiologyMolecular BiologyBiosynthesisProtein Expression	1988	168
Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases Karl Walter Bock, Adelheid Forster, Harald Gschaidmeier, Biochemical Pharmacology BiochemistryMedicineParacetamol GlucuronidationGlycobiologyExperimental Toxicology	1993	139
Defective Initiation of Glycosaminoglycan Synthesis due to B3GALT6 Mutations Causes a Pleiotropic Ehlers-Danlos-Syndrome-like Connective Tissue Disorder Fransiska Malfait, Ariana Kariminejad, Tim Van Damme, The American Journal of Human Genetics Glycosaminoglycan SynthesisAutoimmune DiseaseDefective InitiationDisease MechanismMendelian Disorder	2013	137
Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures. Sylvie Fournel‐Gigleux, L. Sutherland, Nicole Sabolovic, Molecular Pharmacology	1991	105
An Internal Signal Sequence Mediates the Targeting and Retention of the Human UDP-Glucuronosyltransferase 1A6 to the Endoplasmic Reticulum Mohamed Ouzzine, Jacques Magdalou, Brian Burchell, Journal of Biological Chemistry Internal Signal SequenceMolecular BiologyCellular PhysiologyHuman Ugt1a6Protein Expression	1999	101
A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. Michael P. Pritchard, Sylvie Fournel‐Gigleux, Gérard Siest, Molecular Pharmacology	1994	95
Phosphorylation and Sulfation of Oligosaccharide Substrates Critically Influence the Activity of Human β1,4-Galactosyltransferase 7 (GalT-I) and β1,3-Glucuronosyltransferase I (GlcAT-I) Involved in the Biosynthesis of the Glycosaminoglycan-Protein Linkage Region of Proteoglycans Sandrine Gulberti, Virginie Lattard, Magali Fondeur, Journal of Biological Chemistry EngineeringGlycobiologyMolecular BiologyPolysaccharideGlycosaminoglycan-protein Linkage Region	2004	93
Development of Human Liver UDP-Glucuronosyltransferases Brian Burchell, Michael W.H. Coughtrie, Michael R. Jackson, Developmental Pharmacology and Therapeutics ImmunologyPathologyHepatotoxicityLiver SamplesBiochemistry	1989	92

Page 1